Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Oral hypoglycaemic agents

  • 12 Accesses

This is a preview of subscription content, log in to check access.

We’re sorry, something doesn't seem to be working properly.

Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

References

  1. Boyle, D., Bhatia, S. K., Hadden, D. R., Montgomery, D. A. D. and Weaver, J. A. 1972. Ischaemic heart disease in diabetics—a prospective study. Lancet i, 338.

  2. Bloom, A. 1972. Oral therapy in diabetes. J. Roy. Coll. Physns. London, 7, 61.

  3. Chu, P., Conway, M. J., Krause, H. A. and Goodner, C. J. 1968. The pattern of response of plasma insulin and glucose to meals and fasting during chlorpropamide therapy. Ann. Int. Med. 68, 757.

  4. Creutzfeldt, W., Willms, B. and Caspary, W. 1971. The mechanism of action of the blood glucose lowering biguanides. Diabetes: Proceedings of the Seventh Congress of the International Diabetes Federation. 708. Excerpta Medica, Amsterdam 1971.

  5. Emerson, Ralph Waldo. 1803 – 1882. From the hymn sung at the completion of the Concord Monument.

  6. Hadden, D. R., Montgomery, D. A. D. and Weaver, J. A. 1972. Myocardial infarction in maturity onset diabetics. Lancet i, 335.

  7. Hadden, D. R., Boyle, D., Montgomery, D. A. D. and Weaver, J. A. 1973. Risk factors for myocardial infarction in maturity onset diabetes. The Practitioner (in press).

  8. Keen, H. 1970. Minimal diabetes and arterial disease, prevalence and the effect of treatment in early diabetes. New York Academic Press, 437.

  9. Paasikivi, J. and Wahlberg, F. 1971. Preventive tolbutamide treatment and arterial disease in mild hyperglycaemia. Diabetologia 7, 323.

  10. Prout, T. E. 1971. A protective view of the treatment of adult onset diabetes. Med. Clin. N. America, 55, 1065.

  11. Rigas, A. N., Bittles, A. H., Hadden, D. R. and Montgomery, D. A. D. 1968. Circadian variation of glucose, insulin and free fatty acids during longterm use of oral hypoglycaemic agents in diabetes mellitus. Brit. Med. J. iv, 25.

  12. Roth, J. 1971. Sulphonylureas: Effects in vivo and in vitro. Ann. Int. Med. 75, 607.

  13. Seltzer, H. S. 1972. A summary of criticisms of the findings and conclusions of the university Group Diabetes Program. Diabetes 21, 976.

  14. University Group Diabetes Program. 1970. A study of the effects of hypoglycaemic agents on vascular complications in patients with adult-onset diabetes. Diabetes 19, Supplement 2, 747.

  15. Wade, O. L., Hadden, D. R. and Hood, H. 1972. The prescribing of drugs used in the treatment of diabetes. Brit. J. Social and Preventive Med. In press.

  16. Weaver, J. A., Bhatia, S. K., Boyle, D., Hadden, D. R. and Montgomery, D. A. D. 1970. Cardiovascular state of newly discovered female diabetic subjects. Brit. Med. J. i, 783.

Download references

Author information

Correspondence to D. R. Hadden.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Hadden, D.R. Oral hypoglycaemic agents. Ir J Med Sci 142, 11 (1973). https://doi.org/10.1007/BF02947552

Download citation

Keywords

  • Metformin
  • Tolbutamide
  • Coeliac Disease
  • IRISH Journal
  • Chlorpropamide